Results 1 to 10 of about 2,467,329 (421)
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Frontiers in Oncology, 2020Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor involved in homeostatic regulation of normal cells and carcinogenesis of epithelial malignancies.
Wen-Qi Cai+25 more
doaj +2 more sources
Pharmacokinetics of Monoclonal Antibodies
CPT: Pharmacometrics & Systems Pharmacology, 2017Monoclonal antibodies (mAbs) have developed in the last two decades into the backbone of pharmacotherapeutic interventions in a variety of indications, with currently more than 40 mAbs approved by the US Food and Drug Administration, and several dozens ...
J. Ryman, B. Meibohm
semanticscholar +4 more sources
Treatment patterns and factors associated with discontinuation of monoclonal antibodies [PDF]
SAGE Open MedicineBackground: Biological agents have revolutionized care in specialties such as oncology, immunology, infectious diseases, and genetic disorders, offering targeted actions on specific molecules or select immune cells. Monoclonal antibodies, known for their
Muzoon Matar Saleh Alkaabi+3 more
doaj +2 more sources
Kinetic Analysis and Epitope Mapping of Monoclonal Antibodies to Salmonella Typhimurium Flagellin Using a Surface Plasmon Resonance Biosensor [PDF]
Antibodies, 2019Salmonella Typhimurium is one of the leading causes of foodborne diseases worldwide. Biosensors and immunoassays utilizing monoclonal antibodies are widely used for the detection and subtyping of S. Typhimurium.
Devendra Bhandari+3 more
doaj +3 more sources
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Nature, 2021Jianliang Xu+2 more
exaly +2 more sources
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Nature, 2020Jinfang Yu, Jincun Zhao, Jiwan Ge
exaly +2 more sources
Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling+6 more
doaj +1 more source
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling+6 more
doaj +1 more source
Frontiers in Chemistry, 2022
Succinimide (Asu) is the intermediate for asparagine deamidation in therapeutic proteins, and it can be readily hydrolyzed to form aspartate and iso-aspartate residues. Moreover, Asu plays an important role in the protein degradation pathways, asparagine
Tao Liu+22 more
doaj +1 more source
Succinimide (Asu) is the intermediate for asparagine deamidation in therapeutic proteins, and it can be readily hydrolyzed to form aspartate and iso-aspartate residues. Moreover, Asu plays an important role in the protein degradation pathways, asparagine
Tao Liu+22 more
doaj +1 more source
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Nature, 2020David D Ho, Manoj S Nair, Yaoxing Huang
exaly +2 more sources
Pathogens, 2021
Coxiella burnetii is a global, highly infectious intracellular bacterium, able to infect a wide range of hosts and to persist for months in the environment. It is the etiological agent of Q fever—a zoonosis of global priority.
Sílvia da Silva Fontes+10 more
doaj +1 more source
Coxiella burnetii is a global, highly infectious intracellular bacterium, able to infect a wide range of hosts and to persist for months in the environment. It is the etiological agent of Q fever—a zoonosis of global priority.
Sílvia da Silva Fontes+10 more
doaj +1 more source